LY01005

DRUG4 trials

Sponsors

Luye Pharma Group Ltd., The First Affiliated Hospital of Xiamen University

Conditions

Breast CancerCancer of ProstateProstate Cancer

Phase 1

A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer

CompletedNCT03450109

Luye Pharma Group Ltd.Cancer of Prostate

Start: 2017-12-22End: 2018-10-30Updated: 2019-01-07

Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

CompletedNCT05140512

Luye Pharma Group Ltd.Prostate Cancer

Start: 2021-02-04End: 2021-11-26Updated: 2023-05-16

Phase 2

To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer

RecruitingNCT06385847

The First Affiliated Hospital of Xiamen UniversityProstate Cancer

Start: 2024-05-31End: 2025-12-31Target: 60Updated: 2024-04-26

Phase 3

Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®

CompletedNCT05110170

Luye Pharma Group Ltd.Breast Cancer

Start: 2020-10-15End: 2022-06-24Updated: 2023-05-16